Healthcare databases have become the cornerstone of pharmacoepidemiologic research. However, the demonstration of the product value often relies on disease-specific characteristics, such as biomarkers or laboratory test results, which are not routinely recorded in healthcare databases. Finding such fit-for-purpose database is complex considering their heterogeneity in regards to information provided and to access policy. YOLARX has developed a scientific and turn-key solution aiming to identify existing data sources tailored to the needs of our clients. Discover results of 3 recent database mapping projects presented at ICPE on Sunday, 28 August 2016.
Prof. Moride, president and founder of YolaRx Consultants, will be attending at 2016 HTAi Annual Meeting in Tokyo, Japan. Want to meet onsite? Send us an email: firstname.lastname@example.org. Read more